| Literature DB >> 30866832 |
Tanja Rombey1, Katharina Allers2, Tim Mathes3, Falk Hoffmann2, Dawid Pieper3.
Abstract
BACKGROUND: An a priori design is essential to reduce the risk of bias in systematic reviews (SRs). To this end, authors can register their SR with PROSPERO, and/or publish a SR protocol in an academic journal. The latter has the advantage that the manuscript for the SR protocol is usually peer-reviewed. However, since authors ought not to begin/continue the SR before their protocol has been accepted for publication, it is crucial that SR protocols are processed in a timely manner. Our main aim was to descriptively analyse the peer review process of SR protocols published in 'BMC Systematic Reviews' from 2012 to 2017.Entities:
Keywords: Meta-analysis; PROSPERO; Peer review; Protocol; Systematic review
Mesh:
Year: 2019 PMID: 30866832 PMCID: PMC6415341 DOI: 10.1186/s12874-019-0698-8
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Basic characteristics of the included protocols
| Protocol characteristics | |
|---|---|
| Publication year | |
| 2012 | 3.9% |
| 2013 | 10.3% |
| 2014 | 17.0% |
| 2015 | 19.5% |
| 2016 | 22.8% |
| 2017 | 26.7% |
| Country (most common) | |
| Canada | 32.2% |
| UK | 26.1% |
| Other | 22.6% |
| Australia | 7.4% |
| Germany | 7.0% |
| USA | 4.8% |
| Topic area of SR | |
| Therapy (treatment, prevention) | 44.1% |
| Other (i.e. methodology) | 27.0% |
| Epidemiology (i.e. prevalence) | 22.6% |
| Diagnosis | 4.2% |
| Prognosis | 2.0% |
| Source of funding of the SR | |
| Non-profit | 62.9% |
| For-profit/mixed | 2.4% |
| No funding | 18.6% |
| Not reported/unclear | 16.2% |
| Number of authors | |
| Mean (SD) | 6.5 (3.6) |
| Median (IQR) | 6 (4–8) |
| Registered in PROSPERO ( | |
| Before submission / acceptance | 87.4% |
| After submission / acceptance | 2.5% |
| Same day | 10.1% |
Abbreviations: SR Systematic review; SD Standard deviation; IQR Interquartile range
Extent of revision after first round of peer-review and processing times (in days)
| Extent of revision | major ( | minor ( |
|---|---|---|
| Submission to first peer-review | ||
| Days, mean (SD) | 52 (44) | 48 (48) |
| Days, median (IQR) | 40 (25–60) | 33 (21–54) |
| Submission to publication | ||
| Days, mean (SD) | 150 (69) | 119 (65) |
| Days, median (IQR) | 134 (103–177) | 105 (77–143) |
| Submission to acceptance | ||
| Days, mean (SD) | 134 (69) | 104 (65) |
| Days, median (IQR) | 120 (87–157) | 87 (60–124) |
| Acceptance to publication | ||
| Days, mean (SD) | 17 (12) | 15 (9) |
| Days, median (IQR) | 13 (9–20) | 14 (9–18) |
In the remaining protocols (n = 66) there was no reviewer, no revision or no comments from the reviewer entailing a revision
Time trends in basic and peer-review characteristics and processing times
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Overall |
|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ( | ( | ( | |
| Number of protocols registered in PROSPERO, Absolute (%) | 17 (80.1%) | 42 (75.0%) | 81 (88.0%) | 93 (87.7%) | 119 (96.0%) | 133 (91.7%) | 485 (89.2%) |
| Registered prior submission | |||||||
| Absolute (%) | 11 (64.7%) | 30 (71.4%) | 62 (76.5%) | 84 (90.3%) | 112 (94.1%) | 125 (94.0%) | 424 (87.4%) |
| Days, Mean (SD) | 45 (45) | 67 (77) | 78 (110) | 87 (131) | 101 (107) | 110 (129) | 94 (117) |
| Days, Median (IQR) | 22 (7–85) | 43 (13–71) | 36 (11–93) | 29 (8–114) | 71 (28–127) | 62 (22–152) | 49 (15–120) |
| Submission to first peer-review | |||||||
| Days, Mean (SD) | 28 (13) | 35 (24) | 32 (16) | 35 (20) | 55 (55) | 75 (65) | 50 (48) |
| Days, Median (IQR) | 29 (19–42) | 32 (22–41) | 29 (21–41) | 32 (20–46) | 39 (23–70) | 52 (31–95) | 36 (22–57) |
| Submission to acceptance | |||||||
| Days, Mean (SD) | 74 (42) | 77 (44) | 82 (55) | 91 (44) | 109 (52) | 165 (85) | 111 (69) |
| Days, Median (IQR) | 61 (46–105) | 77 (51–95) | 75 (46–105) | 80 (56–117) | 103 (72–138) | 142 (103–214) | 98 (64–139) |
| Submission to publication | |||||||
| Days, Mean (SD) | 91 (43) | 101 (46) | 99 (55) | 110 (47) | 124 (54) | 180 (87) | 128 (70) |
| Days, Median (IQR) | 86 (59–127) | 99 (73–118) | 91 (64–120) | 101 (74–136) | 118 (84–148) | 158 (117–222) | 113 (82–155) |
| Acceptance to publication | |||||||
| Days, Mean (SD) | 17 (21) | 24 (32) | 18 (10) | 18 (12) | 14 (7) | 16 (11) | 17 (15) |
| Days, Median (IQR) | 12 (0–22) | 15 (11–20) | 16 (11–21) | 16 (11–21) | 13 (9–17) | 12 (9–19) | 14 (9–19) |
| Number of reviewers | |||||||
| Mean (SD) | 0.9 (0.6) | 1.1 (0.5) | 1.1 (0.6) | 1.4 (0.8) | 1.1 (0.6) | 1.7 (0.8) | 1.3 (0.7) |
| Median (IQR) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1 (1–2) | 1 (1–1) | 2 (1–2) | 1 (1–2) |
| Number of revisions | |||||||
| Mean (SD) | 0.9 (0.8) | 1.0 (0.5) | 1.2 (0.7) | 1.2 (0.6) | 1.0 (0.4) | 1.2 (0.5) | 1.1 (0.6) |
| Median (IQR) | 1 (0–1) | 1 (1–1) | 1 (1–2) | 1 (1–2) | 1 (1–1) | 1 (1–1) | 1 (1–1) |
| Extent of first revision, Absolute (%) | |||||||
| Major | 4 (19.1%) | 14 (25.0%) | 25 (27.2%) | 38 (35.9%) | 49 (39.5%) | 76 (52.4%) | 206 (37.9%) |
| Minor | 11 (52.4%) | 34 (60.7%) | 52 (56.5%) | 55 (51.9%) | 63 (50.8%) | 57 (39.3%) | 272 (50.0%) |
| No revision required | 1 (4.8%) | 3 (5.4%) | 6 (6.5%) | 2 (1.9%) | 3 (2.4%) | 7 (4.8%) | 22 (4.0%) |
| No (open) peer review | 5 (23.8%) | 4 (7.1%) | 8 (8.7%) | 10 (9.4%) | 8 (6.5%) | 4 (2.8%) | 40 (7.2%) |
| Reviewer report missing | 0 (0%) | 1 (1.8%) | 1 (1.1%) | 1 (0.9%) | 1 (0.8%) | 1 (0.7%) | 4 (0.9%) |
Abbreviations: SD Standard deviation; IQR Interquartile range
Content of reviewers’ comments (including each reviewer and revision)
| Content of reviewers’ comments | Proportion of protocols with comments ( | Comments per protocol (mean ± SD) ( | Proportion of comments suggesting amendments ( | |
|---|---|---|---|---|
| PRISMA-P item | ||||
| 8 | Eligibility criteria | 66.0% | 2.1 ± 2.7 | 16.1% |
| 9 | Information sources | 52.8% | 0.9 ± 1.1 | 39.6% |
| 10 | Search strategy | 34.0% | 0.6 ± 1.2 | 50.0% |
| 11a | Data management | 13.2% | 0.1 ± 0.3 | 0.0% |
| 11b | Selection process | 30.2% | 0.5 ± 0.9 | 12.5% |
| 11c | Data collection process | 24.5% | 0.3 ± 0.7 | 11.1% |
| 12 | Data items | 34.0% | 0.5 ± 0.9 | 31.0% |
| 13 | Outcomes and priorization | 20.8% | 0.4 ± 0.9 | 21.1% |
| 14 | Risk of bias in individual studies | 49.1% | 0.7 ± 0.9 | 31.6% |
| 15a | Criteria for quantitative synthesis | 13.2% | 0.2 ± 0.5 | 11.1% |
| 15b | Aspects of quantitative synthesis | 41.5% | 0.9 ± 1.5 | 14.0% |
| 15c | Additional analyses | 39.6% | 0.7 ± 1.4 | 31.4% |
| 15d | Type of summary if quantitative synthesis not appropriate | 15.1% | 0.2 ± 0.6 | 16.7% |
| 16 | Meta-bias (es) | 17.0% | 0.2 ± 0.4 | 10.0% |
| 17 | Confidence in cumulative evidence | 13.2% | 0.1 ± 0.3 | 42.9% |